by Richard Daverman, PhD
November 29, 2012 -- TTY Biopharm, a Taiwanese drugmaker, officially opened its new $100 million drug manufacturing facility in Suzhou. The new plant, which will be operated by a subsidiary, TOT Biopharm, will produce injectible drugs that treat cancer. Started as a generic drug company in 1960, TTY now also develops innovative medicines, mainly cancer treatments, but also anti-infectives and drugs that treat blood vessel diseases. The company markets its products around the globe. More details....
